Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018850 · ClinicalTrials.gov registry record · NA
5HT3 Antagonism and Auditory Gating in Schizophrenia
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
NCT00018850 is a NA study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018850, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The target groups in this study are brain waves and neurotransmitters (chemical messengers) in the brain. Subjects with diagnosed with schizophrenia will be studied. The study will help understand more about normal brain functioning and how that functioning differs in people with schizophrenia. Another purpose of this study is to determine how the altered brain functioning in schizophrenia contributes the symptoms found in the illness.
Interventions
- DRUG ondansetron
- DRUG nicotine
- DRUG haloperidol
- BEHAVIORAL neuropsychological testing
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-06 |
| Est. Completion | 2003-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018850
The ClinicalTrials.gov registry entry for NCT00018850 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which ondansetron is the first listed.
NCT00018850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018850 about?
NCT00018850 is a clinical study titled "5HT3 Antagonism and Auditory Gating in Schizophrenia". The target groups in this study are brain waves and neurotransmitters (chemical messengers) in the brain. Subjects with diagnosed with schizophrenia will be studied. The study will help understand more about normal brain functioning and how that functioning differs in people with schizophrenia. Anot...
What is the current status of trial NCT00018850?
This trial is currently completed. It is a NA study. The study started on 1998-06. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00018850?
The interventions under investigation include: ondansetron (DRUG), nicotine (DRUG), haloperidol (DRUG), neuropsychological testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00018850?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.